{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:34:50Z","timestamp":1794537290984,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA15083"],"award-info":[{"award-number":["P30CA15083"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011542","name":"Mayo Clinic Center for Clinical and Translational Science","doi-asserted-by":"publisher","award":["P50CA136393"],"award-info":[{"award-number":["P50CA136393"]}],"id":[{"id":"10.13039\/100011542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ygyno.2025.10.028","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T23:02:49Z","timestamp":1762383769000},"page":"165-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quantifying opportunities to reduce high grade serous ovarian cancer via opportunistic salpingectomy"],"prefix":"10.1016","volume":"203","author":[{"given":"Kristin M.","family":"Tischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia S.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela E.","family":"McGree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian E.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise D.","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanika","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie N.","family":"Bakkum-Gamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2025.10.028_bb0005","series-title":"Ovarian Cancer Statistics","author":"National Cancer Institute","year":"2023"},{"key":"10.1016\/j.ygyno.2025.10.028_bb0010","series-title":"Ovarian Cancer Facts & Figures","author":"American Cancer Society","year":"2023"},{"key":"10.1016\/j.ygyno.2025.10.028_bb0015","series-title":"Ovarian cancer","author":"Ovarian Cancer Research Alliance","year":"2025"},{"issue":"4","key":"10.1016\/j.ygyno.2025.10.028_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2025.10.028_bb0025","article-title":"Serous tubal intraepithelial carcinoma (STIC) outcomes in an average risk population","volume":"51","author":"Stewart","year":"2024","journal-title":"Gynecol. Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.028_bb0030","doi-asserted-by":"crossref","first-page":"dju410","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2025.10.028_bb0035","series-title":"Tumors of the Breast and Female Genital Organs. World Health Organization Classification of Tumours: Pathology and Genetics","author":"Tavassoli","year":"2003"},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.028_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from opportunistic salpingectomy for ovarian Cancer prevention","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.ygyno.2025.10.028_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2014.10.005","article-title":"Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma","volume":"135","author":"Lessard-Anderson","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.10.028_bb0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"4","key":"10.1016\/j.ygyno.2025.10.028_bb0055","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1097\/AOG.0000000000003164","article-title":"Opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention","volume":"133","author":"ACOG Committee Opinion No. 774","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.10.028_bb0060","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ijgo.15884","article-title":"FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy","volume":"167","author":"Mor-Hadar","year":"2024","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"4","key":"10.1016\/j.ygyno.2025.10.028_bb0065","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e53","article-title":"Should national societies recommend opportunistic salpingectomy?","volume":"28","author":"Tamussino","year":"2017","journal-title":"J. Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2025.10.028_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Ovarian Cancer research program of British Columbia. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.028_bb0075","doi-asserted-by":"crossref","first-page":"172.e1","DOI":"10.1016\/j.ajog.2018.05.019","article-title":"Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada","volume":"219","author":"Hanley","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.028_bb0080","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2020.02.005","article-title":"Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada","volume":"223","author":"Hanley","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.028_bb0085","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/AOG.0000000000000630","article-title":"Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy","volume":"125","author":"Kwon","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ygyno.2025.10.028_bb0090","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamasurg.2023.4164","article-title":"Salpingectomy for the primary prevention of ovarian Cancer: a systematic review","volume":"158","author":"Kahn","year":"2023","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2025.10.028_bb0100","first-page":"e252810","article-title":"Gauging the magnitude of missed opportunity for ovarian cancer prevention","author":"Moufarrij","year":"2025","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2025.10.028_bb0095","series-title":"Opportunistic salpingectomy: Update from British Columbia, Canada","author":"Hanley","year":"2025"},{"key":"10.1016\/j.ygyno.2025.10.028_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2024.108117","article-title":"Risk-stratified screening and colorectal cancer incidence and mortality: a retrospective study from the prostate, lung, colorectal, and ovarian Cancer screening trial","volume":"187","author":"Zhang","year":"2024","journal-title":"Prev. Med."},{"issue":"10022","key":"10.1016\/j.ygyno.2025.10.028_bb0120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"issue":"10290","key":"10.1016\/j.ygyno.2025.10.028_bb0125","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2025.10.028_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum. Reprod. Update"},{"issue":"23","key":"10.1016\/j.ygyno.2025.10.028_bb0135","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1001\/jama.1993.03510230051034","article-title":"Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study","volume":"270","author":"Hankinson","year":"1993","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.028_bb0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.10.028_bb0145","doi-asserted-by":"crossref","first-page":"399.e1","DOI":"10.1016\/j.ajog.2021.06.074","article-title":"Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States","volume":"225","author":"Mandelbaum","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ygyno.2025.10.028_bb0155","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.surg.2018.03.024","article-title":"Would women accept opportunistic (prophylactic) salpingectomy at the time of nongynecologic surgery to prevent development of ovarian cancer?","volume":"164","author":"Tomasch","year":"2018","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.ygyno.2025.10.028_bb0160","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/bjs.11419","article-title":"Prophylactic salpingectomy for prevention of ovarian cancer at the time of elective laparoscopic cholecystectomy","volume":"107","author":"Tomasch","year":"2020","journal-title":"Br. J. Surg."},{"issue":"9","key":"10.1016\/j.ygyno.2025.10.028_bb0165","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/bjs\/znad203","article-title":"Opportunistic salpingectomy during non-gynaecological surgery in the United States: a population-based retrospective study","volume":"110","author":"Cathcart","year":"2023","journal-title":"Br. J. Surg."},{"issue":"4","key":"10.1016\/j.ygyno.2025.10.028_bb0170","doi-asserted-by":"crossref","first-page":"397.e1","DOI":"10.1016\/j.ajog.2021.03.032","article-title":"The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage","volume":"225","author":"Naumann","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2025.10.028_bb0105","series-title":"Multiplying the Impact of Opportunistic Salpingectomy in the United States","author":"Stone","year":"2025"},{"key":"10.1016\/j.ygyno.2025.10.028_bb0175","article-title":"Salpingectomy for ovarian cancer prevention: video education for the surgeon","volume":"53","author":"MacArthur","year":"2024","journal-title":"Gynecol. Oncol. Rep."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825010522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825010522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:35:22Z","timestamp":1773095722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825010522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S0090825825010522"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.10.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying opportunities to reduce high grade serous ovarian cancer via opportunistic salpingectomy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}